CLOFAZIMINE
UNII D959AE5USF

Substance Identification & Data

This profile provides standardized clinical and technical data for Clofazimine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D959AE5USF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2030-63-9 and the RxNorm Concept ID (RxCUI) 2592. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

D959AE5USF

CAS Registry Number

2030-63-9

RxNorm Concept ID

2592

Detailed Substance Profile

Preferred Name

CLOFAZIMINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C27H22Cl2N4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WDQPAMHFFCXSNU-BGABXYSRSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C47456

National Cancer Institute reference terminology for clinical and research data.

INN ID

2248

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

CC(C)/N=c/1\cc2-c(cc1Nc3ccc(cc3)Cl)nc4ccccc4n2-c5ccc(cc5)Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Clofazimine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.